Poxviruses EQA/PT Pilot Study

In 2022 the global outbreak of mpox began and continues to this day. This resulted in an increasing demand for laboratory preparedness, we have introduced a pilot EQA scheme for poxviruses that will include inactivated monkeypox virus and other orthopoxviruses (Cowpox, and Vaccinia). This offers laboratories, that have recently set up generic orthopoxvirus or specific monkeypox virus molecular diagnostics, the opportunity to assess the performance of their assays.